Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis.

Publication Title

J Thorac Oncol

Document Type

Article

Publication Date

5-5-2023

Keywords

washington; swedish cancer; Clonal hematopoiesis; Lung cancer risk; Mosaic chromosomal alterations

Abstract

Mosaic chromosomal alterations (mCAs) detected in white blood cells represent a type of clonal hematopoiesis (CH) that is understudied compared to CH-related somatic mutations. A few recent studies indicated their potential link with non-hematological cancers, especially lung cancer. In this study, we investigated the association between mCAs and lung cancer using the high-density genotyping data from the OncoArray study of INTEGRAL-ILCCO, the largest single genetic study of lung cancer with 18,221 lung cancer cases and 14,825 cancer-free controls. We identified a comprehensive list of autosomal mCAs, ChrX mCAs, and mosaic ChrY (mChrY) losses from these samples. Autosomal mCAs were detected in 4.3% of subjects, in addition to ChrX mCAs in 3.6% of females and mChrY losses in 9.6% of males. Multivariable logistic regression analysis indicated that the presence of autosomal mCAs in white blood cells was associated with an increased lung cancer risk after adjusting for key confounding factors including age, sex, smoking status, and race. This association was mainly driven by a specific type of mCAs

Clinical Institute

Cancer

Specialty

Oncology

Specialty

Pulmonary Medicine

DOI

10.1016/j.jtho.2023.05.001

Share

COinS